Long-term efficacy safety terazosin combination antihypertensive agents open multicenter phase III study efficacy long-term safety terazosin mg/day combination antihypertensive drugs patients mild essential hypertension baseline values long-term terazosin monotherapy combination therapy consistent decreases systolic diastolic blood pressures mean reduction supine diastolic pressure mm Hg numbers patients controlled blood pressure last evaluable visit therapy period terazosin terazosin added diuretic diuretic added terazosin diuretic added beta-blocker adverse events mild moderate severity pain extremities incidence long-term treatment period initial short-term treatment period syncopal events initial days treatment incidence comparable short-term studies case syncope terazosin monotherapy Terazosin safe effective long-term medication treatment hypertension 